Going Up to 5mg Mounjaro: What Happens at This Dose Stage

Mounjaro is a prescription-only, once-weekly injectable medicine whose active substance is tirzepatide. It acts on both GLP-1 and GIP receptors — pathways involved in appetite regulation and blood-sugar management. According to the electronic Medicines Compendium (eMC), tirzepatide is typically started at 2.5mg once weekly, with the dose increased in a stepped, prescriber-led schedule over several months. The 5mg dose is the first step up in that sequence.

Why the low starting dose exists

The 2.5mg starting dose is not a therapeutic target in itself — it is designed to let the body adjust gradually and reduce the likelihood of gastrointestinal side effects such as nausea, indigestion, and diarrhoea. Moving to 5mg follows the same logic: it is the next increment, not a jump straight to the full maintenance dose. Many people find side effects are more noticeable in the days immediately after a dose change, often settling as the body adjusts.

Can you go straight to 5mg without starting at 2.5mg?

Whether someone can skip the 2.5mg stage is a clinical question for their prescriber, who will weigh up the individual's history and circumstances. Content here cannot advise on that. If you have questions about whether moving to 5mg Mounjaro is right for you, that conversation belongs with the person who prescribed your medication.

What about the equivalent Wegovy dose?

Wegovy (semaglutide) and Mounjaro (tirzepatide) are different medicines with different active substances and dose ranges, so a direct milligram-for-milligram comparison is not clinically meaningful. If you are curious about how the two medicines differ in general terms, that is worth raising with your prescriber rather than drawing equivalence from dose numbers alone.

For a broader look at this dose stage, see our overview of what to expect on 5mg Mounjaro and the practical detail on the transition from 2.5mg to 5mg Mounjaro.

Keeping a clear record of exactly when you moved to 5mg — and how you felt in the days that followed — turns your personal experience into useful, shareable information. That is where GLP Trackr's dose logging comes in.

Every injection can be logged with its dose strength, date, and time, so you always have an accurate history of your titration journey. When a dose change coincides with a shift in how you feel — more nausea, a change in appetite, a dip in energy — the side-effect tracker lets you note those patterns as they happen rather than trying to recall them weeks later at an appointment. The app's doctor report feature can then pull that logged data into a clear summary you can bring to your next prescriber visit, making the conversation about whether to stay at 5mg or consider the next step much more informed.

You can also set a weekly dose reminder so the change in schedule does not catch you off guard — useful when you are moving from one pen strength to another for the first time.

For a full guide to managing this dose stage, visit our Mounjaro 5mg hub.

A note on safety: any decision about your dose — including when to increase, whether to stay at 5mg longer, or what to do if you feel unwell after a change — should be made with your prescriber or doctor. If you experience symptoms that feel severe or persistent after moving to a new dose, contact your healthcare professional promptly. GLP Trackr helps you record what is happening so you can discuss it with them; it is not a substitute for their clinical judgement.

Log your first 5mg injection and track how the transition goes — GLP Trackr is free to try for 7 days on the App Store and Google Play.